SPP1+ macrophages in HR+ breast cancer are associated with tumor-infiltrating lymphocytes
Open Access
- 30 September 2024
- journal article
- research article
- Published by Springer Nature in npj Breast Cancer
- Vol. 10 (1) , 1-12
Abstract
Breast cancer categorized into hormone receptor-positive (HR+), HER2-positive (HER2+), and triple-negative (TNBC) subtypes, exhibits varied outcomes based on the number of tumor-infiltrating lymphocytes (TILs). To explore the divergent roles of TIL levels across different subtypes, we employed single-cell RNA sequencing on 31 patients with breast cancer. HR+ breast cancer with high TIL levels (TIL-high) revealed increased SPP1+ macrophages, increased SPP1 expression in other monocytes/macrophages (mono/macro) subgroups, and enriched pathways associated with extracellular matrix (ECM) remodeling in mono/macro. Moreover, cell–cell interaction analyses revealed enhanced SPP1, MIF, and FN1 signaling in the interaction between SPP1+ macrophages and T-cells in TIL-high HR+ breast cancer. Spatial transcriptomics data highlighted the close proximity of SPP1+ macrophages, CD8+ T-cells, and CD4+ T-cells in TIL-high HR+ breast cancer. Our findings unveil the novel influence of SPP1+ macrophages on T-cells in TIL-high HR+ breast cancer, potentially explaining the poor prognosis and offering insights for targeted interventions.Keywords
All Related Versions
Funding Information
- Asan Institute for Life Sciences, Asan Medical Center (A20221175, A20221175, A20221175, A20221175, A20221175, A20221175, A20221175, A20221175, A20221175, A20221175)
- National Research Foundation of Korea (NRF-2018R1D1A1B07048831, NRF-2018R1D1A1B07048831, NRF-2018R1D1A1B07048831, NRF-2018R1D1A1B07048831, NRF-2018R1D1A1B07048831, NRF-2018R1D1A1B07048831, NRF-2018R1D1A1B07048831, NRF-2018R1D1A1B07048831, NRF-2018R1D1A1B07048831, NRF-2018R1D1A1B07048831)
This publication has 53 references indexed in Scilit:
- Massively parallel digital transcriptional profiling of single cellsNature Communications, 2017
- Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer SubtypesJAMA Oncology, 2016
- Fibrotic microenvironment promotes the metastatic seeding of tumor cells via activating the fibronectin 1/secreted phosphoprotein 1-integrin signalingOncotarget, 2016
- ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualizationMolecular BioSystems, 2015
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Annals of Oncology, 2014
- Osteopontin Shapes Immunosuppression in the Metastatic NicheCancer Research, 2014
- Inflammation-induced interstitial migration of effector CD4+ T cells is dependent on integrin αVNature Immunology, 2013
- Osteopontin Promotes Vascular Endothelial Growth Factor–Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine MechanismsCancer Research, 2008
- Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activationCytokine, 2006
- Regulation of the CTL Response by Macrophage Migration Inhibitory FactorThe Journal of Immunology, 2001